Endocrinology Medical News about Osteoclastogenesis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dendritic Cell-Associated Osteoclastogenesis and Bone Loss
Clinical Reviews in Bone and Mineral Metabolism , 10/27/09

Liu Y–C G et al. – Herein, the author summarizes, discusses and presents a synoptic review of recent evidence, with the focus on the role(s) of DC at the osteo–immune cross–road as the alternative osteoclastogenesis pathway/mechanism(s) underlying inflammation–induced bone loss.

<< Previous
Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase...

Next >>
Predicting poor perinatal outcome in women who present with...

The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells
The Prostate, 10/30/09 Relevance Score: 84%

Relaxin stimulates osteoclast differentiation and activation
Bone, 11/10/09 Relevance Score: 80%

Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the NF-B signal
Molecular Pharmacology, 10/19/09 Relevance Score: 80%

Index Radial Collateral Ligament Repair with Titanium Mini-Suture Anchor: Osteolysis Complication of an Underreported Injury
HAND, 10/19/09 Relevance Score: 80%